The third quarter featured 21 device M&A transactions, 10 of which had disclosed values that together totaled $7.1bn, versus the second quarter, when 14 deals totaled $2bn. Three transactions cracked the billion dollar mark compared to only one deal meeting this milestone in the second quarter.
Q3’s top device M&A deal was ICU Medical’s definitive agreement to acquire the Smiths Medical division of Smiths...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?